Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enko is a private U.S. agricultural life sciences company developing crop protection products for weeds, fungal diseases, and other agricultural pests. The company applies a pharma-style discovery model to agriculture through its ENKOMPASS platform, which combines DNA-encoded libraries, artificial intelligence, machine learning, and structure-based design to discover selective small-molecule crop health products. Enko is focused on novel modes of action intended to address pesticide resistance and improve safety and sustainability. Its disclosed pipeline includes herbicide and fungicide programs, including a graminicide portfolio and partnered discovery work with Syngenta. The company is headquartered in Mystic, Connecticut and remains privately held and active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enko Chem.